Inozyme Pharma, Inc. - FORM S-1 - EX-23.1 - July 2, 2020

Attached files

file filename
EX-21.1 - EX-21.1 - Inozyme Pharma, Inc.d919364dex211.htm
EX-10.20 - EX-10.20 - Inozyme Pharma, Inc.d919364dex1020.htm
EX-10.19 - EX-10.19 - Inozyme Pharma, Inc.d919364dex1019.htm
EX-10.18 - EX-10.18 - Inozyme Pharma, Inc.d919364dex1018.htm
EX-10.17 - EX-10.17 - Inozyme Pharma, Inc.d919364dex1017.htm
EX-10.16 - EX-10.16 - Inozyme Pharma, Inc.d919364dex1016.htm
EX-10.14 - EX-10.14 - Inozyme Pharma, Inc.d919364dex1014.htm
EX-10.13 - EX-10.13 - Inozyme Pharma, Inc.d919364dex1013.htm
EX-10.12 - EX-10.12 - Inozyme Pharma, Inc.d919364dex1012.htm
EX-10.11 - EX-10.11 - Inozyme Pharma, Inc.d919364dex1011.htm
EX-10.10 - EX-10.10 - Inozyme Pharma, Inc.d919364dex1010.htm
EX-10.4 - EX-10.4 - Inozyme Pharma, Inc.d919364dex104.htm
EX-10.3 - EX-10.3 - Inozyme Pharma, Inc.d919364dex103.htm
EX-10.2 - EX-10.2 - Inozyme Pharma, Inc.d919364dex102.htm
EX-10.1 - EX-10.1 - Inozyme Pharma, Inc.d919364dex101.htm
EX-3.2 - EX-3.2 - Inozyme Pharma, Inc.d919364dex32.htm
EX-3.1 - EX-3.1 - Inozyme Pharma, Inc.d919364dex31.htm
S-1 - S-1 - Inozyme Pharma, Inc.d919364ds1.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated May 8, 2020, in the Registration Statement (Form S-1) and related Prospectus of Inozyme Pharma, Inc. dated July 2, 2020.

/s/ Ernst & Young LLP

Boston, Massachusetts

July 2, 2020

Inozyme Pharma, Inc. Reports